The strategy of the Synthos Group
is to build the Company’s corporate value by upgrading innovation, and marketing modern technologically advanced products.
The Synthos CARE research team is based in the Jagiellonian Center of Innovation in Kraków, where it utilises its broad knowledge in biotechnology and nanotechnology to develop advanced systems for carriers of active substances dedicated to cosmetics, dietary supplements, and pharmaceuticals. More than 50% of the members of the research team hold a PhD in natural sciences, mainly in biotechnology and chemistry.
In 2017, a new line for the production of advanced liposome carriers – the only one in this part of Europe – was launched in JCI. It is currently being certified in accordance with the ISO 22000 and ISO 22716 standards.
Thanks to cooperation with the Life Science Cluster in Kraków, as well as with numerous research centres throughout Europe, we have access to the latest scientific achievements, which we are successfully using in our projects.